Your browser doesn't support javascript.
loading
A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre.
Cheema, Parneet K; Iafolla, Marco A J; Nematollahi, Massey; Berco, FeRevelyn; Kaushik, Deepanjali; Matthews, Priscilla; Raskin, William R; Perdrizet, Kirstin A; Dudani, Shaan; Husain, Juhi; Balcewicz, Margaret; Kuruvilla, Philip G; Reingold, Stephen M; Conter, Henry J.
Afiliación
  • Cheema PK; Medical Oncology/Hematology, William Osler Health System, Brampton, ON L6R 3J7, Canada.
  • Iafolla MAJ; Medical Oncology/Hematology, William Osler Health System, Brampton, ON L6R 3J7, Canada.
  • Nematollahi M; Medical Oncology/Hematology, William Osler Health System, Brampton, ON L6R 3J7, Canada.
  • Berco F; Medical Oncology/Hematology, William Osler Health System, Brampton, ON L6R 3J7, Canada.
  • Kaushik D; Medical Oncology/Hematology, William Osler Health System, Brampton, ON L6R 3J7, Canada.
  • Matthews P; Medical Oncology/Hematology, William Osler Health System, Brampton, ON L6R 3J7, Canada.
  • Raskin WR; Medical Oncology/Hematology, William Osler Health System, Brampton, ON L6R 3J7, Canada.
  • Perdrizet KA; Medical Oncology/Hematology, William Osler Health System, Brampton, ON L6R 3J7, Canada.
  • Dudani S; Department of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Husain J; Medical Oncology/Hematology, William Osler Health System, Brampton, ON L6R 3J7, Canada.
  • Balcewicz M; Medical Oncology/Hematology, William Osler Health System, Brampton, ON L6R 3J7, Canada.
  • Kuruvilla PG; Medical Oncology/Hematology, William Osler Health System, Brampton, ON L6R 3J7, Canada.
  • Reingold SM; Medical Oncology/Hematology, William Osler Health System, Brampton, ON L6R 3J7, Canada.
  • Conter HJ; Medical Oncology/Hematology, William Osler Health System, Brampton, ON L6R 3J7, Canada.
Curr Oncol ; 29(2): 869-880, 2022 02 04.
Article en En | MEDLINE | ID: mdl-35200573

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Guideline Límite: Humans País/Región como asunto: America do norte Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Guideline Límite: Humans País/Región como asunto: America do norte Idioma: En Año: 2022 Tipo del documento: Article